Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab – (Eye 30, 79 (January 2016))
Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab Eye 30, 79 (January 2016). doi:10.1038/eye.2015.175 Authors: T D Papakostas, L Lim, T van Zyl, J B Miller, B S Modjtahedi, C M Andreoli, D Wu, L H Young, I K Kim, D G Vavvas,
Nasolacrimal duct intubation in the treatment of congenital nasolacrimal duct obstruction in older children – (Eye 30, 85 (January 2016))
Nasolacrimal duct intubation in the treatment of congenital nasolacrimal duct obstruction in older children Eye 30, 85 (January 2016). doi:10.1038/eye.2015.189 Authors: S Okumuş, V Öner, C Durucu, E Coşkun, Ü Aksoy, E Durucu, L Şahin & I Erbağcı
Meeting the UK driving vision standards with reduced contrast sensitivity – (Eye 30, 89 (January 2016))
Meeting the UK driving vision standards with reduced contrast sensitivity Eye 30, 89 (January 2016). doi:10.1038/eye.2015.188 Authors: S Rae, K Latham & M F Katsou
Primary posterior continuous curvilinear capsulorhexis combined with diffractive multifocal intraocular lens implantation – (Eye 30, 95 (January 2016))
Primary posterior continuous curvilinear capsulorhexis combined with diffractive multifocal intraocular lens implantation Eye 30, 95 (January 2016). doi:10.1038/eye.2015.201 Author: M Ouchi
Depth evaluation of intended vs actual intacs intrastromal ring segments using optical coherence tomography – (Eye 30, 102 (January 2016))
Depth evaluation of intended vs actual intacs intrastromal ring segments using optical coherence tomography Eye 30, 102 (January 2016). doi:10.1038/eye.2015.202 Authors: R Barbara, A Barbara & M Naftali